DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development
10th July, 2023
DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR's microRNA panels and other factors for risk assessment in Alzheimer's disease and Rett syndrome.
Image Source : Public Domain
Alidad Mireskandari, Ph.D., DiamiR's CEO commented that "applying Machine Learning capabilities to our microRNA platform is a key step towards validation of our diagnostic tests. We are excited about partnering with JADBio, a leader in Automated Machine Learning in life sciences, to develop sophisticated, proprietary ML based testing algorithms to further our development efforts."
"We are thrilled to be partnering with DiamiR," said JADBio's CEO, Pavlos Charonyktakis, "as we are confident that our state-of-the-art ML platform and services will prove instrumental in DiamiR's efforts to efficiently validate their biomarker panels and develop highly accurate diagnostic tests."
Medtech Special
- Roche revolutionizes diagnostics with cobas mass spec solution
- Abbott announces first-in-world leadless pacing procedures in the left bundle branch area of the heart
- BD and Babson Diagnostics launch innovative fingertip blood testing to health care organizations
- Implantica adds a ninth RefluxStop™ Center of Excellence
- Medtech firm Getinge opens new Experience Centre in Mumbai
- WHO announces first prequalification of tuberculosis diagnostic test
- Chi Mei Medical Center and Microsoft: Transforming Healthcare with AI and Smart Technology
Artificial Intelligence Breakthroughs
- Samsung invests in generate biomedicines to advance AI-driven therapeutics
- India-based 'Mahajan Imaging and Labs' launches AI-powered lab in Gurugram
- Saudi Arabia to develop AI and data science solution for tackling tuberculosis
- How AI is Propelling Radiology & Medical Imaging Capabilities
- Generative AI: Revolutionizing Diagnostics and Personalized Care
- Indian startup Qure.ai joins hands with Roche to transform healthcare capabilities in APAC
- A10 Networks Launches Integrated AI and Security Solutions to Strengthen Cybersecurity in Healthcare and Beyond
Robots In Medtech
- India's SS Innovations makes history with first robotic cardiac surgery in Indonesia
- Momentis Surgical Secures FDA Clearance for Advanced Anovo® Robotic Platform, Setting New Standards in Single-Incision Surgery
- Momentis Surgical expands to general surgery market with FDA 510(k) clearance for its Anovo Robotic system
- Intuitive and India-based KIMS Hospitals sign MoU to launch 25 new robotic surgery programmes
- ZEISS introduces its latest Robotic Visualisation System for neuro surgery
- Surgical robotics pioneer Intuitive opens Global Capability Centre in Bengaluru, India
- First-of-its-kind robotic cardiac CoE unveiled in Bengaluru, India
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer